larsen
le
tegtmeier
c
pedersen
e
bovin
respiratori
syncyti
viru
brsv
pneumonia
beef
calf
herd
despit
vaccin
acta
vet
scand
present
report
describ
clinic
patholog
serolog
virolog
find
calv
larger
danish
beef
herd
experienc
outbreak
pneumonia
calv
vaccin
inactiv
bovin
respiratori
syncyti
viru
brsv
vaccin
month
prior
outbreak
clinic
sign
compris
nasal
discharg
pyrexia
cough
increas
respiratori
rate
total
calv
die
herd
laboratori
investig
reveal
brsv
involv
probabl
initi
outbreak
furthermor
serolog
result
suggest
vaccin
induc
spars
level
antibodi
probabl
due
presenc
matern
deriv
antibodi
time
vaccin
necropsi
find
calv
reveal
chang
typic
infecti
pneumonia
involv
brsv
conclus
vaccin
calv
brsv
danish
beef
herd
fail
protect
calv
sever
even
fatal
brsv
mediat
respiratori
diseas
month
later
bovin
respiratori
syncyti
viru
brsv
vaccin
enzoot
pneumonia
serolog
calv
respiratori
diseas
one
import
health
problem
young
danish
cattl
substanti
financi
loss
industri
tegtmeier
et
al
uttenth
et
al
thu
approxim
materi
bovin
submit
danish
veterinari
laboratori
dvl
necrosi
origin
cattl
histori
respiratori
symptom
bovin
respiratori
syncyti
viru
brsv
recognis
recent
year
major
viral
compon
bovin
respiratori
diseas
brd
complex
larsen
base
high
preval
seroposit
individu
uttenth
et
al
uttenth
et
al
strong
correl
respiratori
diseas
detect
viru
diagnost
sampl
larsen
et
al
brsv
predilect
lower
respiratori
tract
may
damag
respiratori
tract
epithelium
directli
follow
chang
induc
ie
inflammatori
mediat
kimman
et
al
andor
may
increas
abil
bacteria
invad
lung
caus
secondari
bacteri
infect
babiuk
et
al
far
possibl
prove
clear
link
protect
level
activ
produc
passiv
acquir
antibodi
natur
brsv
infect
thu
calv
less
month
frequent
infect
brsv
despit
presenc
matern
deriv
antibodi
furthermor
reinfect
occur
even
seroposit
calv
van
der
poel
et
al
antibodi
may
partli
protect
howev
sinc
incid
sever
diseas
seem
invers
relat
level
specif
matern
antibodi
kimman
et
al
sever
inactiv
modifi
live
brsv
vaccin
commerci
avail
northamerica
europ
yet
none
regist
use
denmark
septemb
approxim
danish
beef
herd
confirm
brsv
posit
statu
receiv
temporari
permiss
use
inactiv
vaccin
brsv
calv
present
report
describ
clinic
patholog
serolog
virolog
find
vaccin
calv
danish
beef
herd
experienc
outbreak
pneumonia
januari
two
beef
cattl
herd
produc
approxim
calv
year
includ
herd
new
calv
age
week
purchas
differ
sourc
everi
second
month
calv
rear
group
differ
hous
system
indoorsystem
calv
kept
group
outdoor
system
calv
kept
group
calf
hutch
herd
b
calv
purchas
rear
describ
herd
month
howev
calv
herd
transfer
separ
farm
nearbi
kept
tradit
indoor
system
slaughter
month
age
veterinarian
describ
manag
farm
excel
accord
specif
suppli
vendor
dose
betapropiolactoneinactiv
vaccin
contain
least
snu
snu
quantiti
necessari
obtain
seroneutralis
antibodi
guineapig
inactiv
brsv
aluminium
hydroxychlorid
saponin
adjuv
herd
calv
receiv
subcutan
vaccin
ml
per
calf
per
vaccin
week
arriv
respect
accord
manufactur
guidelin
vaccin
program
finalis
decemb
st
calv
inspect
daili
sign
diseas
indic
rectal
temperatur
measur
data
shown
case
clinic
sign
increas
rectal
temperatur
veterinarian
inspect
calv
eventu
initi
treatment
antibiot
nasal
swab
virolog
plain
blood
sampl
serolog
taken
calv
clinic
sign
respiratori
diseas
herd
previous
describ
uttenth
et
al
second
blood
sampl
taken
week
later
calv
five
dead
calv
herd
b
necropsi
locat
macroscop
find
record
lung
transport
dvl
bacteriolog
mycoplasma
examin
histolog
process
perform
previous
describ
tegtmeier
et
al
virolog
materi
necropsi
calv
nasal
swab
test
presenc
brsv
bovin
corona
viru
bcv
bovin
viru
bovin
viral
diarrhoea
viru
bvdv
antigen
elisa
previous
describ
uttenth
et
al
meyl
test
infecti
bovin
rhinotrach
ibr
viru
routin
perform
sinc
denmark
consid
free
infect
serum
sampl
test
presenc
specif
antibodi
brsv
includ
igm
iga
isotyp
brsv
neutralis
serum
antibodi
snt
describ
elsewher
uttenth
et
al
addit
pair
serum
sampl
test
antibodi
bcv
previous
describ
uttenth
et
al
advers
effect
seen
calv
herd
follow
vaccin
herd
sever
outbreak
respiratori
diseas
start
januari
clinic
sign
compris
nasal
discharg
pyrexia
cough
elev
respiratori
rate
mark
depress
almost
calv
month
age
less
affect
total
calv
die
outbreak
herd
b
respect
outbreak
ceas
within
week
tabl
virolog
serolog
find
vaccin
calv
acut
outbreak
respiratori
diseas
herd
herd
b
b
nasal
swab
taken
acut
phase
jan
pair
serum
sampl
taken
acut
phase
one
month
later
feb
nasal
swab
analys
presenc
bovin
respiratori
syncyti
viru
brsv
bovin
corona
viru
bcv
viru
antigen
ag
elisa
serum
sampl
analys
presenc
antibodi
brsv
igm
iga
igg
igg
isotyp
neutralis
antibodi
snt
bcv
ab
ab
signific
chang
antibodi
titer
defin
either
seroconvers
titer
least
fourfold
rise
dead
calf
die
two
sampl
date
na
applic
insuffici
amount
sampl
test
herd
howev
prolong
treatment
primarili
antibiot
sever
affect
calv
necessari
addit
week
result
virolog
serolog
analysi
detail
tabl
brsv
antigen
detect
nasal
swab
sampl
anim
one
die
none
test
calv
igm
iga
antibodi
brsv
first
sampl
day
wherea
calv
moder
level
iga
one
month
later
initi
titer
low
increas
titer
one
month
later
absent
calv
first
sampl
low
titer
remain
calv
howev
titer
increas
high
titer
second
sampl
thu
surviv
calv
signific
titer
rise
brsv
specif
antibodi
sampl
similarli
level
neutralis
antibodi
snt
increas
rather
low
high
titer
one
calf
sampl
bcv
antigen
detect
calv
one
calf
signific
rise
bcv
specif
antibodi
sampl
none
calv
show
rise
specif
antibodi
result
virolog
serolog
analysi
detail
tabl
viru
specif
antigen
detect
nasal
swab
sampl
anim
calv
die
sampl
day
pair
serum
sampl
avail
calv
four
test
calv
igm
andor
iga
antibodi
brsv
first
sampl
day
addit
calv
low
level
iga
one
month
later
includ
calv
iga
neg
first
sampl
initi
titer
high
one
calf
signific
rise
titer
sampl
present
low
level
calv
first
sampl
increas
moder
high
titer
second
sampl
calv
test
level
neutralis
antibodi
snt
vari
titer
first
sampl
increas
two
calv
initi
low
titer
clear
correl
level
brsv
specif
antibodi
initi
sampl
fate
calf
ie
calv
low
well
high
snt
titer
die
sampl
day
three
calv
signific
rise
bcv
specif
antibodi
sampl
one
calv
seroconvert
viru
titer
necropsi
acut
bronchopneumonia
character
red
consolid
tissu
interstiti
edema
mark
interstiti
emphysema
observ
case
result
histopatholog
microbiolog
find
summar
tabl
ureaplasma
diversum
u
diversum
isol
either
alon
concomitantli
one
case
histolog
examin
reveal
fibrinousnecrot
pneumonia
case
wherea
remain
three
case
diagnos
suppur
bronchopneumonia
case
variabl
number
syncyti
cell
seen
detect
brsv
antigen
calv
serolog
respons
major
calv
strongli
indic
brsv
involv
outbreak
herd
similarli
presenc
brsv
antigen
necropsi
calv
serolog
respons
suggest
also
true
outbreak
herd
b
previou
studi
pathogenesi
brsv
infect
shown
brsv
antigen
may
detect
nasal
swab
materi
day
day
post
infect
larsen
et
al
vilcek
et
al
studi
kinet
brsv
specif
antibodi
isotyp
serum
reveal
igm
iga
may
present
day
day
kimman
et
al
detect
day
peak
day
remain
detect
month
halflif
day
schrijver
et
al
kimman
et
al
isotyp
appear
serum
day
peak
day
last
least
month
thu
detect
antigen
nasal
caviti
lack
igm
iga
first
sampl
herd
indic
sampl
taken
shortli
infect
ie
prior
day
contrari
situat
herd
lack
antigen
nasal
swab
presenc
igm
iga
herd
b
indic
first
sampl
taken
later
day
infect
time
detect
amount
snt
antibodi
may
produc
respons
activ
infect
especi
vaccin
calv
see
rel
high
titer
snt
encount
herd
b
first
sampl
necessarili
repres
antibodi
induc
vaccin
similarli
low
snt
titer
first
sampl
herd
may
repres
either
residu
matern
deriv
antibodi
antibodi
induc
vaccin
whatsoev
low
titer
indic
either
vaccin
induc
low
level
antibodi
vanish
time
sampl
approxim
month
last
vaccin
failur
vaccin
induc
higher
titer
antibodi
may
due
either
poor
immunigen
presenc
moder
high
level
matern
deriv
antibodi
time
vaccin
thu
presenc
matern
natur
acquir
antibodi
shown
suppress
local
system
antibodi
respons
follow
experiment
brsv
infect
ciszewski
et
al
kimman
et
al
interestingli
studi
also
reveal
memori
respons
might
mount
even
absenc
detect
primari
respons
seroposit
calv
therefor
vaccin
calv
may
display
stronger
rapid
system
antibodi
respons
challeng
inde
high
snt
titer
second
sampl
herd
surplu
titer
normal
seen
natur
infect
calv
uttenth
et
al
publish
field
trial
live
inactiv
brsv
vaccin
reveal
differ
level
protect
fulton
et
al
kubota
et
al
howard
et
al
verhoeff
van
nieuwstadt
mohanti
et
al
other
found
vaccin
enhanc
diseas
calv
gershwin
et
al
kimman
et
al
kimman
cowork
investig
effect
rout
administr
matern
antibodi
protect
effect
modifi
live
inactiv
vaccin
kimman
et
al
isol
one
lung
addit
brsv
antigen
detect
case
find
accord
previou
microbiolog
studi
pneumon
calf
lung
tissu
multipl
pathogen
frequent
isol
tegtmeier
et
al
presenc
one
isol
microorgan
may
like
contribut
develop
sever
pneumonia
howev
viral
agent
brsv
usual
consid
primari
pulmonari
pathogen
capabl
destroy
respiratori
epitheli
line
degre
allow
agent
colon
babiuk
et
al
former
studi
tegtmeier
et
al
perform
pneumon
lung
tissu
submit
dvl
diagnost
purpos
brsv
antigen
often
detect
case
suppur
bronchopneumonia
syncyti
cell
interstiti
emphysema
could
observ
syncyti
cell
interstiti
emphysema
featur
present
case
necropsi
present
studi
therebi
indic
brsv
present
examin
lung
signific
rise
bcv
specif
antibodi
calv
herd
b
presenc
high
titer
bcv
antibodi
sampl
calv
herd
confirm
previou
find
bcv
common
danish
cattl
larsen
et
al
howev
associ
presenc
bcv
bcv
antibodi
outbreak
respiratori
diseas
still
controversi
martin
et
al
experiment
infect
bcv
fail
induc
fulmin
respiratori
diseas
heckert
et
al
detect
bcv
nasal
swab
specif
rise
bcv
titer
strongli
correl
outbreak
respiratori
diseas
larg
survey
recent
perform
danish
dairi
herd
alban
et
al
thu
present
bcv
may
consid
involv
brd
complex
viru
probabl
capabl
induc
fulmin
respiratori
diseas
without
presenc
contribut
factor
interpret
bcv
serolog
virolog
data
complic
fact
diagnost
assay
employ
distinguish
bcv
strain
involv
brd
strain
involv
enter
infect
conclus
data
obtain
present
investig
strongli
indic
brsv
involv
probabl
initi
outbreak
brd
despit
prior
vaccin
inactiv
brsv
vaccin
compani
withdrew
vaccin
european
mark
earli
spring
artiklen
beskriv
de
klinisk
patologisk
serologisk
og
virologisk
fund
kalv
fra
dansk
slagtekalvebesaetning
forbindels
med
udbrud
af
alvorlig
lungebetaendels
kalven
var
vaccineret
med
en
inaktiveret
vaccin
mod
bovin
respiratorisk
syncyti
viru
brsv
tidliger
de
klinisk
symptom
omfatted
nasal
feber
host
og
respirationsfrekven
alt
kalv
de
besaetning
vist
brsv
var
involveret
og
formodentligt
begg
udbrud
ydermer
vist
resultatern
af
de
serologisk
test
vaccinen
kun
inducered
lave
maengder
af
antistoff
formodentlig
grund
af
tilstedevaerels
af
maternel
antistoff
vaccinationstidspunktet
obdukt
af
fem
kalv
vist
forandring
typisk
lungebetaendels
af
brsv
baggrund
af
de
beskrevn
fund
kunn
det
konkluder
vaccin
med
en
inaktiveret
brsv
vaccin
ikk
beskytted
kalven
mod
alvorlig
og
fatal
lungebetaendels
efter
sidst
vaccin
